Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Pulsatile vs Sustained GH Elevation Profiles

Endogenous GH secretion follows a pulsatile pattern. Discrete bursts every 3–5 hours, with the largest pulse occurring 60–90 minutes after sleep onset. This pulsatility is critical for downstream signaling: IGF-1 synthesis in the liver, lipolysis in adipose ti

This comparison does not assign a generated winner or score.

  • Endogenous GH secretion follows a pulsatile pattern. Discrete bursts every 3–5 hours, with the largest pulse occurring 60–90 minutes after sleep onset. This pulsatility is critical for downstream signaling: IGF-1 synthesis in the liver, lipolysis in adipose tissue, and protein synthesis in muscle all respond more robustly to pulsatile GH than to continuous elevation. Research protocols examining these pathways must match the appropriate peptide profile to the hypothesis being tested.
  • Ipamorelin replicates endogenous pulsatility more faithfully than any other peptide secretagogue. A 2017 study in the Journal of Endocrinology found that ipamorelin administered at 100 mcg/kg produced GH peaks of 8–12 ng/mL within 20 minutes, returning to baseline within 90 minutes. Nearly identical to the physiological pulse pattern observed in young adults. Importantly, ipamorelin does not elevate cortisol or prolactin at therapeutic doses, which makes it ideal for isolating GH-specific effects without confounding hormonal changes.
  • CJC-1295 with DAC produces the opposite profile: sustained elevation without discrete pulses. Plasma GH levels remain 2–3× above baseline for 5–7 days following a single injection, which more closely mimics exogenous GH replacement than endogenous secretion. This makes CJC-1295 with DAC useful for protocols examining long-term anabolic effects, but inappropriate for studies requiring intact circadian GH dynamics.
  • GHRP-2 occupies a middle ground. It produces moderate GH pulses (4–6 ng/mL peak) with a half-life of 20–30 minutes, but also stimulates ghrelin receptors in the hypothalamus, increasing appetite and gastric motility. This dual action is valuable in metabolic research but complicates protocols where food intake must remain controlled.
More references

Related material